Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.
about
Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Anti-Neoplastic Cytotoxicity o ...... mentary Effect of Mebendazole.
@ast
Anti-Neoplastic Cytotoxicity o ...... mentary Effect of Mebendazole.
@en
type
label
Anti-Neoplastic Cytotoxicity o ...... mentary Effect of Mebendazole.
@ast
Anti-Neoplastic Cytotoxicity o ...... mentary Effect of Mebendazole.
@en
prefLabel
Anti-Neoplastic Cytotoxicity o ...... mentary Effect of Mebendazole.
@ast
Anti-Neoplastic Cytotoxicity o ...... mentary Effect of Mebendazole.
@en
P2093
P2860
P356
P1476
Anti-Neoplastic Cytotoxicity o ...... mentary Effect of Mebendazole.
@en
P2093
P2860
P356
10.17303/JCRTO.2014.203
P577
2014-04-01T00:00:00Z